Literature DB >> 11419941

cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland.

S Sanghi1, R Kumar, A Lumsden, D Dickinson, V Klepeis, V Trinkaus-Randall, H F Frierson, G W Laurie.   

Abstract

Multiple extracellular factors are hypothesized to promote the differentiation of unstimulated and/or stimulated secretory pathways in exocrine secretory cells, but the identity of differentiation factors, particularly those organ-specific, remain largely unknown. Here, we report on the identification of a novel secreted glycoprotein, lacritin, that enhances exocrine secretion in overnight cultures of lacrimal acinar cells which otherwise display loss of secretory function. Lacritin mRNA and protein are highly expressed in human lacrimal gland, moderately in major and minor salivary glands and slightly in thyroid. No lacritin message or protein is detected elsewhere among more than 50 human tissues examined. Lacritin displays partial similarity to the glycosaminoglycan-binding region of brain-specific neuroglycan C (32 % identity over 102 amino acid residues) and to the possibly mucin-like amino globular region of fibulin-2 (30 % identity over 81 amino acid residues), and localizes primarily to secretory granules and secretory fluid. The lacritin gene consists of five exons, displays no alternative splicing and maps to 12q13. Recombinant lacritin augments unstimulated but not stimulated acinar cell secretion, promotes ductal cell proliferation, and stimulates signaling through tyrosine phosphorylation and release of calcium. It binds collagen IV, laminin-1, entactin/nidogen-1, fibronectin and vitronectin, but not collagen I, heparin or EGF. As an autocrine/paracrine enhancer of the lacrimal constitutive secretory pathway, ductal cell mitogen and stimulator of corneal epithelial cells, lacritin may play a key role in the function of the lacrimal gland-corneal axis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11419941     DOI: 10.1006/jmbi.2001.4748

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

Review 1.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

Review 2.  Focus on molecules: lacritin.

Authors:  Peisong Ma; Ningning Wang; Robert L McKown; Ronald W Raab; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2007-02-16       Impact factor: 3.467

3.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 4.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

5.  Detection of prosecretory mitogen lacritin in nonprimate tears primarily as a C-terminal-like fragment.

Authors:  Diane E Laurie; Rebecca K Splan; Kari Green; Katherine M Still; Robert L McKown; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-12       Impact factor: 4.799

Review 6.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

7.  A thermo-responsive protein treatment for dry eyes.

Authors:  Wan Wang; Aarti Jashnani; Suhaas R Aluri; Joshua A Gustafson; Pang-Yu Hsueh; Frances Yarber; Robert L McKown; Gordon W Laurie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2014-12-03       Impact factor: 9.776

8.  Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity.

Authors:  Francisco Velez V; Jeffrey A Romano; Robert L McKown; Kari Green; Liwen Zhang; Ronald W Raab; Denise S Ryan; Cindy M L Hutnik; Henry F Frierson; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

9.  Conserved regional 3' grouping of rare codons in the coding sequence of ocular prosecretory mitogen lacritin.

Authors:  Robert L McKown; Ronald W Raab; Patricia Kachelries; Sara Caldwell; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-19       Impact factor: 4.799

10.  Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells.

Authors:  Atsuko Fujii; Ayumi Morimoto-Tochigi; Ryan D Walkup; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.